comparemela.com

Latest Breaking News On - Us army medical research development - Page 1 : comparemela.com

Large study of J&J s HIV vaccine stopped after shot found ineffective

Inhalon Collaborates with Celltrion, Inc to Develop Nebulized Form of Regdanvimab to Treat COVID-19 Patients at Home

Inhalon Collaborates with Celltrion, Inc to Develop Nebulized Form of Regdanvimab to Treat COVID-19 Patients at Home
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ACHL) - The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ACHL) - The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Regulus Announces Addition to Board of Directors

Regulus Announces Addition to Board of Directors News provided by Share this article LA JOLLA, Calif., Jan. 27, 2021 /PRNewswire/  Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced Alice S. Huang, Ph.D. has been appointed to the Company s board of directors. Concurrently with her appointment to the Board, Dr. Huang was appointed to serve on the Compensation Committee. We are pleased to add Dr. Huang to the Regulus board.  We believe her extensive scientific background will be of benefit to helping direct the Company s drug discovery and development programs, said Stelios Papadopoulos, Ph.D., Chairman of the Board of Directors of Regulus. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.